ad image

Charles River Laboratories

1 / 2
Is AI truly transforming drug development, or are we still navigating through the hype?
AI

Is AI truly transforming drug development, or are we still navigating through the hype?

Pharma's Almanac

PAO-02-25-RT-01Feb 26, 2025
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Changing Roles

How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?

Pharma's Almanac

PAO-08-24-RT-01Aug 07, 2024
How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?
Global Access

How Can (Bio)pharmaceutical Companies Contribute to Improving Global Access to Essential Medications?

Pharma's Almanac

PAO-08-24-RT-02Aug 07, 2024
How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?
Commitment to ESG Principles

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

Pharma's Almanac

PAO-03-24-CL-03Mar 08, 2024
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Accelerating Product Development

What strategies are being employed to accelerate product development and commercialization without compromising quality?

Pharma's Almanac

PAO-03-24-CL-02Mar 08, 2024
Wheeler Bio
Portable CMC

Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC® to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Wheeler Bio

PR-M02-29-01Feb 29, 2024
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

PAO-09-23-RT-02Sep 15, 2023
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

PAO-07-23-RT-01Jul 21, 2023
Wheeler Bio
Biologics Testing Lab

Wheeler Bio and Charles River Laboratories Announce Agreement to Build and Operate RightSource℠ Laboratory

Wheeler Bio

PR-M06-23-01May 31, 2023
Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data
Preclinical Data

Transforming Drug Development with Frictionless Access to Real-Time Preclinical Data

Mark Mintz; Kristen M. Eisenhauer

Charles River Laboratories

PAO-05-23-CL-03May 05, 2023
Charles River Laboratories
Cloud-Based Platform

Charles River Launches Apollo™, an Industry-Leading, Secure, Cloud-Based Platform for Real-Time Toxicology Study Data

Charles River Laboratories

PR-M03-23-03Mar 14, 2023
What do you view as the most disruptive or transformational technology or development on the horizon?
Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

PAO-01-23-RT-01Jan 31, 2023
Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery
Computational Drug Design

Integrating Experimental Data and Artificial Intelligence to Accelerate Drug Discovery

Ronald Dorenbos, Ph.D.; Guido Lanza

Charles River Laboratories

PAO-11-022-CL-11-180Dec 07, 2022
What key indicators do you look at to predict the future of this industry?
Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

PAO-10-022--RT-02Oct 11, 2022
What is your plan to build a more sustainable business practice in the coming years?
Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

PAO-10-022--RT-01Oct 11, 2022
Wheeler Bio
Series A Funding

Wheeler Bio Announces Initial Closing of Series A Round Supporting New Biologics Drug Substance GMP Expansion In Oklahoma

Wheeler Bio

PR-M10-22-02Oct 05, 2022
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

PAO-06-022--RT-01Jun 24, 2022
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

O-06-022--RT-01Jun 24, 2022
Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?
Personalized and Precision Medicine

Q: What do you see as the key innovations or technologies that will make personalized/precision medicine a reality?

Pharma's Almanac

PAO-12-21-RT-01Jan 07, 2022
Charles River
M&A

Charles River Laboratories Completes the Acquisition of HemaCare Corporation

Charles River

PR-M01-20-NI-005Jan 03, 2020
1 / 2